Nan Wu
About Nan Wu
Nan Wu is a scientist at Bristol Myers Squibb in New Brunswick, New Jersey, with extensive experience in biopharmaceutical research and development.
Current Role at Bristol Myers Squibb
Nan Wu is currently employed as a Scientist at Bristol Myers Squibb, located in New Brunswick, New Jersey, United States. In this role, Nan Wu is involved in biopharmaceutical research, specifically contributing to the development of innovative therapies for serious diseases. This position entails engagement in scientific research and development, clinical trials, and collaborative projects with academic institutions and research organizations. The work focuses on personalized treatments and advancing therapies in areas including oncology, cardiovascular, and immunology.
Previous Experience at Regeneron
In 2021, Nan Wu worked at Regeneron in Tarrytown, New York, United States, specializing in formulation development for a period of six months. This role involved applying skills in biopharmaceutical research and development to create and optimize formulations that support pharmaceutical advancements. The brief tenure at Regeneron contributed significantly to Nan Wu's expertise in the development processes within the pharmaceutical industry.
Roles in Academic and Research Institutions
Between 2016 and 2021, Nan Wu served as a Research Assistant at Lehigh University in Pennsylvania, where significant research was conducted in the field of chemical engineering. Prior to that, from 2014 to 2015, Nan Wu was a Research Assistant at Illinois Institute of Technology in Chicago, Illinois. These roles involved extensive scientific research, particularly focusing on the development of innovative experimental platforms and advancements in chemical engineering. Additionally, Nan Wu spent a month as a Collaboration Visiting Scientist at the University of Colorado Boulder in 2019, further expanding the scope of academic collaboration and research expertise.
Educational Background in Chemical Engineering
Nan Wu earned a Doctor of Philosophy (PhD) in Chemical Engineering from Lehigh University, where studies were conducted from 2016 to 2021. This advanced degree followed a Master’s degree in Chemical Engineering from Illinois Institute of Technology, obtained between 2013 and 2015. The educational background provided a strong foundation in chemical engineering principles and methodologies, which were crucial in Nan Wu’s subsequent roles in research and development within both academic and corporate settings.
Key Research Projects and Innovations
During graduate studies, Nan Wu developed a gut-on-a-chip microfluidic device to simulate the transient pH environment through each organ in the gastrointestinal tract. Another significant project involved using multiple particle tracking microrheology (MPT) to analyze the dynamic microstructures and material property evolution of covalent adaptable hydrogels (CAHs). Nan Wu also created an experimental platform, μ2rheology, to study CAH degradation in response to temporal pH changes. Furthermore, research demonstrated the CAH's ability to degrade and spontaneously reform in the GI tract, suggesting new strategies for targeted oral drug or nutrient delivery. By covalently tethering model drugs into CAH and quantifying the dynamic release through digestion, Nan Wu designed an effective vehicle for controlled, targeted oral drug delivery.